Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Robert A. Burger, MD

Robert A. Burger, MD Physician

Director of Clinical Research and Fellowship Program in Gynecologic Oncology Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania

Dr. Burger is employed by Penn Medicine.

About Dr. Robert A. Burger

Recognized by America's Top Doctors, 2014 - 2018

Recognized by Best Doctors in America - 2013 - 2018

Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Gynecologic Oncology

Programs & Centers:

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1999
  • Obstetrics and Gynecology, 1997

Clinical Expertise:

  • Abdominal Dermoid Cyst
  • Adenocarcinoma In Situ of the Cervix
  • Adenocarcinoma of Cervix
  • Adnexal Mass
  • Bartholin's Gland Carcinoma
  • CA 125 Elevation
  • Cancer During Pregnancy
  • Cancer of the Myometrium
  • Cancer of the Oviduct
  • Carcinosarcoma
  • Cervical and Endometrial Cancers
  • Cervical Cancer
  • Cervical Conization
  • Cervical Dysplasia
  • Cervical Intraepithelial Neoplasia
  • Choriocarcinoma
  • Cold Knife Cone Biopsy of the Cervix
  • Complex Pelvic Surgery
  • Dysgerminoma of Ovary
  • Endometrial Cancer
  • Endometrial Hyperplasia
  • Fallopian Tube Cancer
  • Familial Ovarian Cancer
  • Gestational Trophoblastic Disease
  • Gynecologic Cancer Care
  • Gynecologic Surgery
  • Hereditary Breast and Ovarian Cancer
  • HGSIL Pap Smear
  • Hydatiform Mole
  • Labial Cancer
  • Laparoscopic Oophorectomy
  • Laparoscopic Pelvic Lymphadenectomy
  • Leiomyoma
  • Leiomyosarcoma
  • Leiomyosarcoma of the Uterus
  • LGSIL Pap Smear
  • Malignant Neoplasm of Mesovarium
  • Ovarian Cancer
  • Ovarian Cancer Risk Assessment
  • Ovarian Debulking Surgery
  • Ovarian Tumors
  • Paget's Disease of the Vulva
  • Partial Vulvectomy
  • Pelvic Lymphadenectomy
  • Pelvic Malignancy During Pregnancy
  • Pelvic Mass
  • Postmenopausal Adnexal Mass
  • Primary Peritoneal Cancer
  • Prophylactic Oophorectomy
  • Pseudomyxoma Peritonei
  • Radical Hysterectomy
  • Radical Trachelectomy
  • Radical Vulvectomy
  • Recurrent Cervical Cancer
  • Sentinel Lymph Node Biopsy
  • Squamous Cell Carcinoma of the Cervix
  • Squamous Intraepithelial Neoplasia
  • Surgical Staging
  • Teratoma
  • Teratoma of Ovary
  • Urethral Cancer
  • Uterine Cancer
  • Uterine Mass
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vaginal Intraepithelial Neoplasia
  • Vulvar Mass
  • Vulvectomy
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: New York University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: UC at Irvine Medical Center


American Association for Cancer Research (AACR), National American College of Obstetricians and Gynecologists, National American College of Surgeons (FACS), fellow, National GOG Foundation, National Gynecologic Oncology Group, National National Cancer Institute (NCI), Investigator, National NRG Oncology, International NRG Oncology, National Ovarian Cancer National Alliance Scientific and Medical Advisory Board, National Society of Gynecologic Oncology (SGO), National

Hospital Affiliation

Dr. Burger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Wade K, Brady MF, Thai T, Want Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA: Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218 Gynecol Oncol 155 (1): 69 - 74,2019.

Oved JH, Graul A, Burger RA, Schwartz LE, Reyes MC, Balis FM.: Exceptional Response to Nivolumab in a 13 year old female with metastatic HPV Negative Cervical Carcinoma DNA and Cell Biology 38 (10): 1143 - 1146,2019.

Tewari KT, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.: Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer. J Clin Oncol 37 (26): 2317 - 2328,2019.

Fuh K, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS: Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients Gynecol Oncol 154 (2): 420 - 425,2019.

Nasioudis D, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Ko EM, Latif NA.: Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma. Gynecol Oncol 154 (2): 302 - 307,2019.

Moore KN, Gunderson C, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger R, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE: A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer Gynecol Oncol 154 (2): 294 - 301,2019.

Fruehauf JP, Parmakhtiar B, Burger RA, Kim J-H: HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity Molecular Cancer Research 17 (8): 1675 - 1686,2019.

Cori L, Cha B, Ellenberg S, Bogner HR, Hwang W-T, Smith J, Haggerty A, Morgan M, Burger R, Chu C, Ko E: Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial Obstetrics and Gynecology 134 (2): 376 - 384,2019.

Graul A, Haggerty A, Stickley C, Kumar P, Morales K, Bogner H, Burger R, Morgan M, Ko E.: Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care service among gynecologic oncology patients. Poster Presentation, Annual Meeting of the American Society of Clinical Oncology. (Abstract) : 2019.

Cadoo KA, Meyers ML, Burger RA, Armstrong DK, Penson RT, Gordon MS, Fleming GF, Moroney JW, Hamilton EP, Duska LR, Wenham RM, Sankoh S, Brouwer S, Ordentlich P, Aghajanian C, Matulonis UA.: A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC). Clinical Science Symposium Presentation at the Annual Meeting of the American Society of Clinical Oncology (Abstract) : 2019.

Academic Contact Info

University of Pennsylvania
3400 Civic Center Blvd.
South Tower 10-173

Philadelphia, PA 19104-5156
Phone: (215) 220-9513
Patient appointments: 800-789-7366 (PENN)